RNA Sequencing Analysis of CD4+ T Cells Exposed to Airway Fluid From Children With Pediatric Acute Respiratory Distress Syndrome

Author:

Ripple Michael J.12,Huang Min3,Stephenson Susan T.2,Mohammad Ahmad F.2,Tidwell Mallory1,Fitzpatrick Anne M.12,Kamaleswaran Rishikesan,Grunwell Jocelyn R.12

Affiliation:

1. Division of Pediatric Critical Care Medicine, Children’s Healthcare of Atlanta, Egleston Hospital, Atlanta, GA.

2. Department of Pediatrics, Emory University School of Medicine, Atlanta, GA.

3. Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA.

Abstract

IMPORTANCE:CD4+T cells contribute to lung inflammation in acute respiratory distress syndrome. The CD4+T-cell response in pediatric acute respiratory distress syndrome (PARDS) is unknown.OBJECTIVES:To identify differentially expressed genes and networks using a novel transcriptomic reporter assay with donor CD4+T cells exposed to the airway fluid of intubated children with mild versus severe PARDS.DESIGN:In vitro pilot study.SETTING:Laboratory-based study using human airway fluid samples admitted to a 36-bed university-affiliated pediatric intensive care unit.PATIENTS/SUBJECTS:Seven children with severe PARDS, nine children with mild PARDS, and four intubated children without lung injury as controls.INTERVENTIONS:None.MEASUREMENTS AND MAIN RESULTS:We performed bulk RNA sequencing using a transcriptomic reporter assay of CD4+T cells exposed to airway fluid from intubated children to discover gene networks differentiating severe from mild PARDS. We found that innate immunity pathways, type I (α and β), and type II (γ) interferon response and cytokine/chemokine signaling are downregulated in CD4+T cells exposed to airway fluid from intubated children with severe PARDS compared with those with mild PARDS.CONCLUSIONS:We identified gene networks important to the PARDS airway immune response using bulk RNA sequencing from a novel CD4+T-cell reporter assay that exposed CD4+T cells to airway fluid from intubated children with severe and mild PARDS. These pathways will help drive mechanistic investigations into PARDS. Validation of our findings using this transcriptomic reporter assay strategy is needed.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3